Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3505 | 1969 | 40.4 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
219 | 3 | PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS//PROTEIN FOLDING//PROTEIN STRUCTURE PREDICTION | 50409 |
1067 | 2 | ANGIOGENIN//RIBONUCLEASE//MOLTEN GLOBULE | 9981 |
3505 | 1 | ANGIOGENIN//RIBONUCLEASE//RIBONUCLEASE INHIBITOR | 1969 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANGIOGENIN | authKW | 2012806 | 10% | 66% | 198 |
2 | RIBONUCLEASE | authKW | 836222 | 10% | 26% | 205 |
3 | RIBONUCLEASE INHIBITOR | authKW | 725769 | 3% | 84% | 56 |
4 | ONCONASE | authKW | 680563 | 3% | 83% | 53 |
5 | ENGN PROT | address | 446567 | 2% | 80% | 36 |
6 | RIBONUCLEASE A | authKW | 408472 | 4% | 33% | 81 |
7 | BOVINE SEMINAL RIBONUCLEASE | authKW | 294620 | 1% | 100% | 19 |
8 | RNASE A | authKW | 293543 | 3% | 35% | 54 |
9 | BS RNASE | authKW | 232594 | 1% | 100% | 15 |
10 | BIOCHEM BIOPHYS SCI MED | address | 221467 | 2% | 36% | 40 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 11542 | 62% | 0% | 1228 |
2 | Biophysics | 3447 | 16% | 0% | 313 |
3 | Cell Biology | 518 | 10% | 0% | 201 |
4 | Oncology | 438 | 10% | 0% | 192 |
5 | Biochemical Research Methods | 312 | 5% | 0% | 101 |
6 | Genetics & Heredity | 116 | 5% | 0% | 92 |
7 | Evolutionary Biology | 61 | 2% | 0% | 31 |
8 | Biotechnology & Applied Microbiology | 47 | 4% | 0% | 72 |
9 | Medicine, Research & Experimental | 46 | 3% | 0% | 60 |
10 | Crystallography | 39 | 2% | 0% | 37 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENGN PROT | 446567 | 2% | 80% | 36 |
2 | BIOCHEM BIOPHYS SCI MED | 221467 | 2% | 36% | 40 |
3 | SEZ CHIM BIOL | 54671 | 1% | 17% | 21 |
4 | EOSINOPHIL PATHOPHYSIOL SECT | 34888 | 0% | 75% | 3 |
5 | CHEM BIOCHEM BIOL CHEM | 31013 | 0% | 100% | 2 |
6 | DIPARTIMENTO SCI OSTETRICHE GINECOL PEDIAT | 31013 | 0% | 100% | 2 |
7 | ENGINYERIA PROTEINES | 31013 | 0% | 100% | 2 |
8 | MOLEC BIOSCI BIOTECHNOL | 31013 | 0% | 100% | 2 |
9 | CELL RECOGNIT STUDY | 21698 | 0% | 20% | 7 |
10 | KIDNEY INNATE IMMUN GRP | 20674 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEMISTRY | 5142 | 7% | 0% | 135 |
2 | PROTEIN SCIENCE | 3698 | 2% | 1% | 39 |
3 | FEBS JOURNAL | 2380 | 1% | 1% | 29 |
4 | EUROPEAN JOURNAL OF BIOCHEMISTRY | 1659 | 2% | 0% | 47 |
5 | JOURNAL OF MOLECULAR BIOLOGY | 1456 | 2% | 0% | 48 |
6 | CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 1362 | 1% | 1% | 11 |
7 | JOURNAL OF BIOCHEMISTRY | 1251 | 2% | 0% | 30 |
8 | FEBS LETTERS | 1109 | 3% | 0% | 56 |
9 | PROTEIN ENGINEERING | 966 | 1% | 1% | 12 |
10 | BIOPOLYMERS | 742 | 1% | 0% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANGIOGENIN | 2012806 | 10% | 66% | 198 | Search ANGIOGENIN | Search ANGIOGENIN |
2 | RIBONUCLEASE | 836222 | 10% | 26% | 205 | Search RIBONUCLEASE | Search RIBONUCLEASE |
3 | RIBONUCLEASE INHIBITOR | 725769 | 3% | 84% | 56 | Search RIBONUCLEASE+INHIBITOR | Search RIBONUCLEASE+INHIBITOR |
4 | ONCONASE | 680563 | 3% | 83% | 53 | Search ONCONASE | Search ONCONASE |
5 | RIBONUCLEASE A | 408472 | 4% | 33% | 81 | Search RIBONUCLEASE+A | Search RIBONUCLEASE+A |
6 | BOVINE SEMINAL RIBONUCLEASE | 294620 | 1% | 100% | 19 | Search BOVINE+SEMINAL+RIBONUCLEASE | Search BOVINE+SEMINAL+RIBONUCLEASE |
7 | RNASE A | 293543 | 3% | 35% | 54 | Search RNASE+A | Search RNASE+A |
8 | BS RNASE | 232594 | 1% | 100% | 15 | Search BS+RNASE | Search BS+RNASE |
9 | RANPIRNASE | 189949 | 1% | 88% | 14 | Search RANPIRNASE | Search RANPIRNASE |
10 | HUMAN PANCREATIC RIBONUCLEASE | 171760 | 1% | 92% | 12 | Search HUMAN+PANCREATIC+RIBONUCLEASE | Search HUMAN+PANCREATIC+RIBONUCLEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHENG, JH , XU, ZP , (2016) THREE DECADES OF RESEARCH ON ANGIOGENIN: A REVIEW AND PERSPECTIVE.ACTA BIOCHIMICA ET BIOPHYSICA SINICA. VOL. 48. ISSUE 5. P. 399 -410 | 119 | 77% | 6 |
2 | RUTKOSKI, TJ , RAINES, RT , (2008) EVASION OF RIBONUCLEASE INHIBITOR AS A DETERMINANT OF RIBONUCLEASE CYTOTOXICITY.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 9. ISSUE 3. P. 185 -199 | 132 | 77% | 34 |
3 | GOTTE, G , LAURENTS, DV , MERLINO, A , PICONE, D , SPADACCINI, R , (2013) STRUCTURAL AND FUNCTIONAL RELATIONSHIPS OF NATURAL AND ARTIFICIAL DIMERIC BOVINE RIBONUCLEASES: NEW SCAFFOLDS FOR POTENTIAL ANTITUMOR DRUGS.FEBS LETTERS. VOL. 587. ISSUE 22. P. 3601-3608 | 87 | 96% | 2 |
4 | ARDELT, W , ARDELT, B , DARZYNKIEWICZ, Z , (2009) RIBONUCLEASES AS POTENTIAL MODALITIES IN ANTICANCER THERAPY.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 625. ISSUE 1-3. P. 181-189 | 94 | 78% | 54 |
5 | MATOUSEK, J , (2011) RIBONUCLEASES, NUCLEASES AND ANTIANGIOGENINS IN ANTIPROLIFERATIVE ACTIVITIES.CURRENT SIGNAL TRANSDUCTION THERAPY. VOL. 6. ISSUE 3. P. 363-382 | 107 | 70% | 0 |
6 | RAINES, RT , (1998) RIBONUCLEASE A.CHEMICAL REVIEWS. VOL. 98. ISSUE 3. P. 1045 -1065 | 115 | 54% | 587 |
7 | MATOUSEK, J , (2001) RIBONUCLEASES AND THEIR ANTITUMOR ACTIVITY.COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY. VOL. 129. ISSUE 3. P. 175 -191 | 96 | 90% | 87 |
8 | DICKSON, KA , HAIGIS, MC , RAINES, RT , (2005) RIBONUCLEASE INHIBITOR: STRUCTURE AND FUNCTION.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 80. VOL. 80. ISSUE . P. 349 -+ | 85 | 89% | 84 |
9 | DYER, KD , ROSENBERG, HF , (2006) THE RNASE A SUPERFAMILY: GENERATION OF DIVERSITY AND INNATE HOST DEFENSE.MOLECULAR DIVERSITY. VOL. 10. ISSUE 4. P. 585-597 | 93 | 79% | 65 |
10 | SORRENTINO, S , (2010) THE EIGHT HUMAN "CANONICAL" RIBONUCLEASES: MOLECULAR DIVERSITY, CATALYTIC PROPERTIES, AND SPECIAL BIOLOGICAL ACTIONS OF THE ENZYME PROTEINS.FEBS LETTERS. VOL. 584. ISSUE 11. P. 2194 -2200 | 73 | 91% | 32 |
Classes with closest relation at Level 1 |